Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 4451-4460 of 13612

Page
per page
  1. PD-166866
    C9071 PD-166866
    Summary: A highly selective FGFR1 tyrosine kinase inhibitor for in vitro cell signaling pathway research.
  2. PKM2 inhibitor(compound 3k)
    B8217 PKM2 inhibitor(compound 3k)
     1 Citation
    Summary: A potent, selective PKM2 inhibitor
      ≥34.5 mg/mL
  3. Tubeimoside I
    N1601 Tubeimoside I
    Summary: Anti-tumor agent
      ≥131.9 mg/mL
  4. Desoxyrhaponticin
    BA2915 Desoxyrhaponticin
    Summary: Desoxyrhaponticin is an orally effective fatty acid synthase inhibitor with apoptotic effects on human cancer cells.
  5. NADPH (sodium salt)
    C3974 NADPH (sodium salt)
    Summary: Electron donor
      insoluble in EtOH; insoluble in DMSO; ≥52 mg/mL
  6. E7016
    BA4391 E7016
    Summary: E7016 (GPI21016) is an orally effective inhibitor.
  7. Diphenhydramine
    BA1265 Diphenhydramine
    Summary: A first-generation histamine H1 receptor antagonist with anticholinergic activity
      ≥48.5 mg/mL
  8. Cediranib Maleate
    C9067 Cediranib Maleate
    Summary: A selective VEGFR tyrosine kinase inhibitor, for research use only.
  9. Evodiamine
    N1600 Evodiamine
    Summary: Indole alkaloid
      ≥30.3 mg/mL
  10. Leptomycin B
    B6907 Leptomycin B
    Summary: Antifungal antibiotic, inhibitor of the nuclear export of proteins
      ≥98.8 mg/mL

Items 4451-4460 of 13612

Page
per page